TRINITY BIOTECH PLC's ticker is TRIB and the CUSIP is 896438306. A total of 72 filers reported holding TRINITY BIOTECH PLC in Q4 2016. The put-call ratio across all filers is 55.25 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $1,291,000 | -5.9% | 230,145 | +0.7% | 0.00% | -50.0% |
| Q2 2017 | $1,372,000 | +0.8% | 228,609 | +0.1% | 0.00% | 0.0% |
| Q1 2017 | $1,361,000 | -13.9% | 228,391 | +0.0% | 0.00% | 0.0% |
| Q4 2016 | $1,580,000 | -53.2% | 228,373 | -10.6% | 0.00% | -60.0% |
| Q3 2016 | $3,376,000 | +16.6% | 255,360 | 0.0% | 0.01% | 0.0% |
| Q2 2016 | $2,896,000 | +3.6% | 255,360 | +6.5% | 0.01% | 0.0% |
| Q1 2016 | $2,795,000 | – | 239,700 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACK Asset Management | 672,100 | $14,625,000 | 5.62% |
| GOLDMAN CAPITAL MANAGEMENT INC | 312,000 | $6,789,000 | 4.48% |
| Lyon Street Capital, LLC | 407,586 | $8,870,047,000 | 4.37% |
| GREAT POINT PARTNERS LLC | 189,071 | $4,114,000 | 2.85% |
| Adirondack Research & Management Inc. | 161,507 | $3,514,000 | 2.02% |
| Park West Asset Management LLC | 483,355 | $10,518,000 | 1.56% |
| Benchmark Capital Advisors | 56,954 | $1,239,000 | 0.89% |
| WOODMONT INVESTMENT COUNSEL LLC | 76,607 | $1,667,000 | 0.61% |
| SHEPHERD KAPLAN KROCHUK, LLC | 156,000 | $3,394,000 | 0.55% |
| HEARTLAND ADVISORS INC | 1,250,364 | $27,208,000 | 0.50% |